Journal Article

Tumor-infiltrating lymphocytes and breast cancer: Beyond the prognostic and predictive utility

Cavazzoni, Andrea, Roviello, Giandomenico, Ravelli, Andrea, Ferrero, Giuseppina, Bottini, Alberto, Zanotti, Laura, Zanconati, Fabrizio, Alfieri, Roberta, Biondi, Alessandra, Ungari, Marco, Petronini, Pier Giorgio, Cretella, Daniele, Generali, Daniele, Cappelletti, Maria Rosa

2017

Overview

The importance of the immune system as a potent anti-tumor defense has been consolidated in recent times, and novel immune-related therapies are today demonstrating a strong clinical benefit in the setting of several solid neoplasms. Tumor-infiltrating lymphocytes reflect the attempt of the host to eradicate malignancies, and during the last decades, they have been shown to possess an interesting prognostic utility for breast cancer, especially in case of HER2 positive and triple-negative molecular subtypes. In parallel, the clinical evaluation of tumor-infiltrating lymphocytes has been shown to effectively predict treatment outcomes in both neoadjuvant and adjuvant settings. Currently, tumor-infiltrating lymphocytes are promising further predictive utility in view of novel immune-related therapeutic strategies which are coming into the clinical setting launching a solid rationale for the future next-generation treatment options. In this scenario, tumor-infiltrating lymphocytes might represent an important resource for the selection of the most appropriate therapeutic strategy, as well as further evaluations of the molecular mechanisms underlying tumor-infiltrating lymphocytes and the immunoediting process would eventually provide new insights to augment therapeutic success. Considering these perspectives, we review the potential utility of tumor-infiltrating lymphocytes in the definition of breast cancer prognosis and in the prediction of treatment outcomes, along with the new promising molecular-based therapeutic discoveries.

• Publisher: SAGE Publications,Sage Publications Ltd,SAGE Publishing
• Subject: Antigens / Apoptosis / Authorship / Breast cancer / Breast Neoplasms - classification / Breast Neoplasms - immunology / Breast Neoplasms - therapy / Cancer therapies / Chemotherapy / Clinical outcomes / Cloning / Cytotoxicity / Equilibrium / ErbB-2 protein / Female / Humans / Immune system / Immunotherapy / Lymphocytes / Lymphocytes, Tumor-Infiltrating - immunology / Medical prognosis / Molecular modelling / Neoadjuvant Therapy / Prognosis / Treatment Outcome / Tumor-infiltrating lymphocytes / Tumors